← Leaderboards
John Aleman
University Of Colorado Denver
$134,224
Attributed
$134,224
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $45.9K · FY2022–25$50K$37.5K$25K$12.5K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$134,224 · 1
By mechanism
F31$134,224 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Elizabeth J Shpall$12,617,686
- Thomas A Campbell$2,616,890
- Rajesh Agarwal$27,337,251
- Heide L Ford$14,422,349
- Ross M Kedl$19,713,912
Others in their field
Other Rising Stars on “Esophagus”
- Colton Joseph Lloyd · Sinopia Biosciences, Inc.$2,700,762
- Sarah Laun · Capsulomics, Llc$2,691,319
- Nurit P Azouz · Cincinnati Childrens Hosp Med Ctr$2,343,115
- Maral Mousavi · University Of Southern California$2,180,213
- Chelsey Schlechter · University Of Utah$2,147,775
- Jayhun Lee · University Of Texas Hlth Sci Ctr Houston$2,028,609
Research focus
EsophagusDropsAnti-Tumor Immune ResponseAffectAtomic Force MicroscopyDistant MetastasisCancer TypeCd8b1 GeneCd8-Positive T-LymphocytesCancer CellCell LineCancer RiskCellsCancer Stem CellCheckpoint TherapyClustered Regularly Interspaced Short Palindromic RepeatsCollagenCollagen GeneCollagen Type IConsensusCrosslinkDependenceDepositionExclusion
Grant awards (3)
Assessing TGF Beta1-Mediated ECM Remodeling in Metastatic Oral Squamous Cell Carcinoma$45,858
F31 · FY2025 · DE · contact PI
Assessing TGF Beta1-Mediated ECM Remodeling in Metastatic Oral Squamous Cell Carcinoma$45,294
F31 · FY2024 · DE · contact PI
Assessing TGF Beta1-Mediated ECM Remodeling in Metastatic Oral Squamous Cell Carcinoma$43,072
F31 · FY2022 · DE · contact PI